ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes - Wikidata - awgldk - TriplyDB

ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes

ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes

http://www.wikidata.org/entity/Q35088799

about

Th17 Cells in Type 1 Diabetes: Role in the Pathogenesis and Regulation by Gut Microbiome Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH 17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ Circadian molecular clock in lung pathophysiology RORγ antagonists and inverse agonists: a patent review.Phosphoenolpyruvate Carboxykinase, a Key Enzyme That Controls Blood Glucose, Is a Target of Retinoic Acid Receptor-Related Orphan Receptor α Nuclear receptor RORα regulates pathologic retinal angiogenesis by modulating SOCS3-dependent inflammation.Retinoic Acid-Related Orphan Receptors (RORs): Regulatory Functions in Immunity, Development, Circadian Rhythm, and Metabolism.Clock-Enhancing Small Molecules and Potential Applications in Chronic Diseases and Aging.RORα modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis.Metabolism of murine TH 17 cells: Impact on cell fate and function Th17 cells in Type 1 diabetes: a future perspective.Metabolic Characterization of a Novel RORα Knockout Mouse Model without Ataxia Chronomedicine and type 2 diabetes: shining some light on melatonin.Bacillus Calmette-Guérin (BCG) Vaccination in Infancy and Risk of Childhood Diabetes.Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice.Topical ROR Inverse Agonists Suppress Inflammation in Mouse Models of Atopic Dermatitis and Acute Irritant Dermatitis.RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.Development and Therapeutic Potential of Small-Molecule Modulators of Circadian Systems.Redox regulation of circadian molecular clock in chronic airway diseases.Transcription Factor Retinoid-Related Orphan Receptor γt: A Promising Target for the Treatment of Psoriasis.Insights into the Role of Circadian Rhythms in Bone Metabolism: A Promising Intervention Target?The role of RORα in salivary gland lesions in patients with primary Sjögren's syndrome

P2860

Q26769612-297BE634-135A-4018-973A-A4564DF62386 Q27702597-6B15D1C3-6F84-44AF-B578-A1179B88E952 Q28082902-615A3D98-A17F-471C-A9B7-8BA68817F682 Q34540327-16432222-FBD4-4B3E-9A0A-EF1B6FF49E18 Q35780366-0FA58A47-A50E-4CA6-B2F9-0480E5A8672F Q35989713-03A5F4F7-ED9C-4F39-98D8-7E3BF36A38E3 Q36571294-7CD8A651-D130-437B-A986-32B2E86BBE10 Q37699510-5F08BAB6-C15D-45D2-809A-8AA230C73A0B Q38430298-143D03A3-EC96-44CB-903B-C78E958C7CB5 Q38439401-7FC81BF9-A144-4D86-A1F6-E10D5655385B Q38443227-22818EF9-4A60-4A19-8B6E-83DCE028FF4D Q38661300-4061902B-9CD5-4757-B675-B71FF01F9039 Q39040818-68B6242D-8AB4-49E8-9AB3-1716A4330D43 Q40301485-91D28BB0-8FEA-4183-8294-6A05DE801B8A Q43002530-4732AEB4-EADB-4671-9EC4-614F01F1C087 Q47993781-62025834-CA1D-4035-8E3C-B8473B0B45CD Q49039960-9E4180C7-40C1-47B7-B598-4A59AC75B662 Q51793703-B8453EBE-1DC7-4444-841C-252FE9B2A97C Q52685760-CF9E2951-A815-4C59-8272-97A7C888A178 Q55031102-A496E6C9-28EB-409B-A21E-9E85ED599894 Q58548730-262BDC97-1436-4C07-95BA-1566A6A0A7D2 Q58761748-208D5C02-CD92-48AD-8175-A22805248B5F

P2860

ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes

http://www.wikidata.org/entity/Q35088799

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

ROR inverse agonist suppresses ...... mouse model of type 1 diabetes

@ast

ROR inverse agonist suppresses ...... mouse model of type 1 diabetes

@en

type

label

ROR inverse agonist suppresses ...... mouse model of type 1 diabetes

@ast

ROR inverse agonist suppresses ...... mouse model of type 1 diabetes

@en

prefLabel

ROR inverse agonist suppresses ...... mouse model of type 1 diabetes

@ast

ROR inverse agonist suppresses ...... mouse model of type 1 diabetes

@en

P1433

Q35088799-490010C0-0910-48A2-80B8-54E11C264544

P1476

Q35088799-8C5EF008-E064-4EB6-99EE-09433D80C7BF

P2093

Q35088799-0AD43465-A1FC-4B9D-B48F-F711EA1E9D34

Q35088799-A29F1E0B-0BFF-4382-ABA9-1F2F5EBA46CB

Q35088799-C8D27C5F-75A8-48BC-AD9D-BBDD4FBE3FE6

Q35088799-EABEFE5E-7761-43A7-B5E1-C77E345E21B9

P2860

Q35088799-00636236-1025-4F42-972E-AD883CBC8C06

Q35088799-01814F1E-9327-486F-96C4-8CFAE7545780

Q35088799-05222CEA-D847-4E48-AD84-4C8B80925AA8

Q35088799-0E266BA9-FB3B-4FF8-BAB4-9C854258B446

Q35088799-1B14D07E-781B-443C-9FE3-40BBF3741652

Q35088799-27F91804-D67C-4804-8CE6-01A48F940B55

Q35088799-2A183720-1C24-4FF8-AB99-5C2BE97B8A5B

Q35088799-3114C344-7A37-4008-8195-B833602DC43B

Q35088799-36AECC2F-00B5-424E-B42B-A509A8979D5F

Q35088799-3D360072-A66D-4BCB-8FAD-FE5C3FA2C7E2

P304

Q35088799-B0BF6887-ADCC-4503-B0AE-29E65433992F

P31

Q35088799-F913A2F1-FE51-4729-AD0C-EE0791E838BE

P356

Q35088799-0ADB9068-E6D0-4B6E-90F1-0E5A28378839

P407

Q35088799-8ABD356E-0A46-4FA7-B987-A6B9BD0B3546

P433

Q35088799-25B05CAD-6913-4CEB-8EA6-5FCA57299737

P478

Q35088799-9F05E3A2-6DB8-4F53-B399-B54AA482E460

P50

Q35088799-4B138D21-B58E-4B7B-AB47-4DCF2E7EB4DD

P577

Q35088799-3BA2115F-C6B6-45F4-9B1E-1A80504D63DF

P5875

Q35088799-CD626A04-B85C-4AA7-B308-FC4B4170CE3D

P698

Q35088799-FDB3E4E7-BE29-493F-A433-42B3EA27964D

P921

Q35088799-867875B2-FF41-4687-BCCB-52451436C681

Q35088799-A6BBDCEE-F77A-439D-86B9-20332F4F7726

P932

Q35088799-F03813B1-E56B-419F-A6EE-6B4434B566C3

P356

P1433

P1476

ROR inverse agonist suppresses ...... mouse model of type 1 diabetes

@en

P2093

Laura A Solt

http://www.w3.org/2001/XMLSchema#string

Sean Campbell

http://www.w3.org/2001/XMLSchema#string

Subhashis Banerjee

http://www.w3.org/2001/XMLSchema#string

Theodore M Kamenecka

http://www.w3.org/2001/XMLSchema#string

P2860

TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Control of regulatory T cell development by the transcription factor Foxp3

Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1

CCR6 regulates the migration of inflammatory and regulatory T cells

Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death

Increased ischemia-induced angiogenesis in the staggerer mouse, a mutant of the nuclear receptor Roralpha.

Th17 polarized cells from nonobese diabetic mice following mycobacterial adjuvant immunotherapy delay type 1 diabetes.

Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models.

Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes.

P304

869-881

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/EN.2014-1677

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

156

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270651942

http://www.w3.org/2001/XMLSchema#string

P698

25560829

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

4330305

http://www.w3.org/2001/XMLSchema#string